Market forecast for vascular access devices predicts that the industry will mark the development at a CAGR of 6.5%. The growing demand for vascular access systems will elevate the size of the industry from USD 5.4 billion to USD 10.1 billion from 2024 to 2034.
The rising adoption of minimally invasive procedures, driven by advancements in medical technology and patient preference for less invasive options, is a key trend supported by innovations in catheter design and materials. This enhances the patient's comfort and reduces the risk of complications.
A major driver is the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. This drives the demand for vascular access systems for long-term treatment and medication administration.
Technological advancements, such as the integration of digital health solutions and smart catheter technologies, are becoming increasingly prevalent, offering better monitoring and management of vascular access.
Attributes | Key Insights |
---|---|
Vascular Access System Market Size in (2024E) | USD 5.4 billion |
Vascular Access System Market Size (2034F) | USD 10.1 billion |
Value-based CAGR from 2024 to 2034 | 6.5% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
With the aging global population, the prevalence of chronic diseases requiring vascular access, such as renal failure and cancer, also increases.
There is also a notable trend toward growing home healthcare, spurred by the convenience and cost-effectiveness of the methods used. This shift is boosting the demand for vascular access systems that are easy to use and manage outside of traditional healthcare settings.
Advances in vascular access technology enhance the safety, efficacy, and comfort of such devices. This helps devices gain the attention of patients as well as healthcare professionals.
Global vascular access systems market analysis suggests that the increasing healthcare expenditure globally, particularly in developing regions, is expanding access to advanced medical treatments, including vascular access systems.
Market growth of peripheral IV catheters is responsible for the development of the industry, fueling the vascular access system market size. Supportive government policies and initiatives aimed at improving healthcare infrastructure and access are providing a favorable for the future of vascular access devices in healthcare.
Technological innovations, including the development of antimicrobial and anti-thrombogenic coatings, are anticipated to enhance device safety and efficacy, thereby boosting demand.
One significant challenge is the risk of complications associated with vascular access devices, such as infections and thrombosis, which can lead to increased healthcare costs and patient morbidity. This is an adverse regulatory impact on the vascular access systems market. Apart from this, a lack of skilled healthcare professionals trained in the insertion and maintenance of these devices can hinder industry growth.
The United States represents a significant market for vascular access systems, driven by multiple factors. The first driver is the high prevalence of chronic diseases, such as cardiovascular diseases and cancer, which necessitate frequent and long-term vascular access.
Substantial investments in healthcare research and development are leading to continuous innovations in this field. This bolsters the healthcare industry, which promises a better market forecast for vascular access devices.
Favorable reimbursement policies and the emphasis on reducing healthcare-associated infections are boosting the adoption of advanced vascular access solutions. With the effect of such factors, the advanced healthcare infrastructure in the United States supports the widespread adoption of sophisticated vascular access devices.
The high prevalence of chronic diseases, such as diabetes and cancer, is increasing the demand for vascular access devices in the United Kingdom. This requires more attention to reduce the risk of life-threatening diseases.
The United Kingdom's aging population is creating a sustained need for such systems, coupled with the abovementioned factors, particularly for long-term treatments. This drives the demand for central venous catheters, peripheral IV catheters, and other vascular access devices.
National Health Service (NHS) initiatives focused on improving patient outcomes and reducing hospital stay durations are promoting the use of efficient vascular access systems.
The increasing burden of chronic diseases is set to fuel trends in the central venous catheter market. The rising requirement for catheters to mitigate critical diseases like renal failure will drive the industry heavily.
The growing population in the country will likely elevate the number of critically ill patients with such life-threatening diseases. To cater to the demand for such constant medical assistance, more production of vascular access systems must be made.
Peripheral vascular access systems are also expected to rise during the forecast period in India due to the abovementioned factors. The growing medical tourism industry in India is creating additional demand for high-quality vascular access systems.
Central Venous Catheters are anticipated to secure a significant share in the sector due to the critical role of CVCs in many medical treatments. Advances in vascular access technology will effectively drive the segment.
CVCs are widely used in intensive care units (ICUs) and for patients requiring long-term intravenous therapy, such as chemotherapy, total parenteral nutrition, and the administration of medications that are irritating to peripheral veins. The increasing prevalence of chronic diseases, particularly cancer and cardiovascular diseases, which require prolonged and intensive treatment, drives the demand for CVCs.
PICCs are favored for ease of insertion and lower complication rates compared to traditional central venous catheters. PICCs are commonly used for patients who require extended intravenous therapy, including antibiotic administration, chemotherapy, and parenteral nutrition.
The increasing trend towards home healthcare and outpatient treatments is boosting the demand for PICCs, as such devices are suitable for long-term use outside the hospital environment. As a result, the said segment contributes satisfactorily to the share of global vascular access systems.
With the presence of several key players, the competitive landscape exerts a high force on new entrants. To mitigate this force, product innovation can be an effective solution, which also helps new businesses gain a respectable share. Existing players expand using different strategies, including diversification, new product launches, mergers, and acquisitions.
The following are some key recent developments helping the competitive space enhance in terms of the size and share of the industry:
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Teleflex Medical, Access Vascular, Inc., B. Braun, Smith’s Medical (ICU Medical, Inc), Cook Medical, AngioDynamics, Medtronic, Medical Components, Inc., Nipro Medical Corporation, and Terumo Medical Corporation are key competitors in the ecosystem.
Short Peripheral Intravenous Catheters (Short PIVCs), Huber Needles, Midline Catheters, Peripherally Inserted Central Catheters (PICCs), Central Venous Catheters (CVCs), Dialysis Catheters, and Implantable Ports are some key product categories in the sector.
Based on the end-user industry, the competitive landscape can be categorized into Hospitals, Ambulatory Care Centres, and Other End-users.
North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe, and The Middle East and Africa are the key contributing regions to the industry.
The vascular access system market will advance at a CAGR of 6.5% through 2034.
The industry will likely reach USD 10.1 billion by 2034.
The ecosystem will reach USD 5.4 billion in 2024.
The Central Venous Catheters will lead the industry share in 2024.
Market Value for 2023 | USD 1,468.4 million |
---|---|
Market Value for 2033 | USD 2,466.5 million |
Market Forecast CAGR (2023 to 2033) | 5.30% |
Market CAGR (2023 to 2033) | 4.7% |
---|---|
Market Size (2023) | USD 2,737.4 million |
Market Size (2033) | USD 4,344 million |
Market Value (2022) | USD 21.4 billion |
---|---|
Market Forecast Value (2032) | USD 34.20 billion |
Market Expected CAGR (2022 to 2032) | 4.8% |
Estimated market Value (2022) | USD 3.0 billion |
---|---|
Estimated market Value (2032) | USD 5.3 billion |
CAGR (2022 to 2032) | 5.7 % |
Explore Therapeutic Device Insights
View ReportsThank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.